Novartis India (BOM:500672) Short Interest


BOM:500672 Novartis India Ltd BOM:500672
59 GF Score
Price ₹1,452.70
GF Value ₹927.99
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Novartis India Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


BOM:500672 vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Novartis India's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis India Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis India's Short Interest distribution charts can be found below:

* The bar in red indicates where Novartis India's Short Interest falls into.


BOM:500672
59GF Score
Novartis India Ltd BOM:500672
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Novartis India (BOM:500672) Overvalued in 2026?

Based on GuruFocus' analysis, Novartis India stock appears to be overvalued. The current stock price of ₹1,452.70 is trading 56.5% above its estimated GF Value™ of ₹927.99. GuruFocus considers Novartis India to be Significantly Overvalued.

Key valuation signals for BOM:500672:

  • Short Interest:
  • GF Value™: ₹927.99 vs. price of ₹1,452.70 (56.5% above fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the BOM:500672 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Novartis India Business Description

Other Exchanges NOVARTIND:India
Address Inspire BKC, Part of 601 & 701, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company operates in a single business segment, namely Pharmaceutical Business. Its Pharmaceutical business focuses on Bone and Pain, Transplantation Immunology, and Neurosciences.
59GF Score

Get the complete analysis for BOM:500672

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,452.70
Price
₹927.99
GF Value